Ernexa Therapeutics Balance Sheet (2010-2026) | ERNAW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)			0.21M				0.03M				0.11M				0.17M				0.20M
Receivables - Doubtful (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	50.16M	24.38M	16.98M	23.50M	19.41M	13.25M	15.54M	9.49M	5.93M	8.65M	11.67M	9.21M	2.59M	4.26M	1.73M	1.92M	4.32M	3.00M	1.88M	9.18M
Receivables - Net (Quarter)			0.68M
Receivables - Other (Quarter)			0.68M	0.83M	0.69M	0.93M		0.65M	0.98M	1.78M		0.35M	0.23M	0.19M		0.16M	0.15M	0.15M	0.75M	0.10M
Receivables (Quarter)			1.37M
Prepaid Assets (Quarter)	1.75M	1.35M	1.10M	0.80M	1.82M	1.67M	1.28M	0.47M	1.07M	0.70M	1.60M	0.70M	0.77M	0.28M	0.19M	0.14M	0.32M	0.18M	0.40M	0.72M
Current Deferred Tax Assets (Quarter)
Current Assets (Quarter)	51.94M	25.76M	18.77M	25.14M	21.93M	15.85M	13.68M	6.51M	3.89M	7.03M	9.60M	6.16M	3.58M	4.73M	2.35M	2.21M	4.79M	3.38M	3.13M	10.00M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.58M	0.55M	0.67M	0.31M	0.42M	0.23M	0.24M	0.21M	0.19M	0.17M	0.49M	0.71M	0.65M	0.10M	0.09M	0.07M	0.05M	0.09M	0.09M	0.09M
Long-Term Investments (Quarter)		1.00M	1.00M	0.39M	0.09M	0.07M	0.06M	0.01M
Goodwill (Quarter)	2.04M	2.04M	2.04M	2.00M	2.04M	2.00M	2.00M	2.00M	2.04M	2.00M	2.04M	2.04M	2.00M	2.00M	2.04M	2.04M	2.04M	2.04M	2.04M	2.00M
Intangibles (Quarter)	5.99M	5.99M	5.99M	6.00M
Goodwill & Intangibles (Quarter)	8.03M	8.03M	8.03M	8.00M	2.04M	2.00M	2.00M	2.00M	2.04M	2.00M	2.04M	2.04M	2.00M	2.00M	2.04M	2.04M	2.04M	2.04M	2.04M	2.00M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.51M	0.52M		0.06M	0.48M	0.82M	1.13M	1.24M	4.09M	4.04M	4.10M	0.12M	4.09M	0.12M	0.12M	0.12M	0.12M	0.12M	0.11M	0.11M
Non-Current Assets (Quarter)	12.77M	13.64M	12.76M	10.24M	4.98M	5.07M	8.60M	8.59M	43.06M	45.22M	39.53M	43.49M	42.90M	2.99M	2.92M	2.85M	2.79M	2.79M	2.70M	0.55M
Assets (Quarter)	64.71M	39.39M	31.52M	35.38M	26.90M	20.93M	22.28M	15.11M	46.95M	52.25M	49.13M	49.66M	46.49M	7.72M	5.27M	5.06M	7.58M	6.17M	5.83M	10.54M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.68M	1.00M	1.75M	1.11M	1.48M	1.15M	1.62M	1.46M	2.67M	1.46M	1.07M	2.06M	2.19M	2.19M	1.72M	1.27M	1.32M	0.96M	1.12M	1.30M
Notes Payables (Quarter)																2.25M
Payables (Quarter)	3.68M	1.00M	1.75M	1.11M	1.48M	1.15M	1.62M	1.46M	2.67M	1.46M	1.07M	2.06M	2.19M	2.19M	1.72M	3.52M	1.32M	0.96M	1.12M	1.30M
Accumulated Expenses (Quarter)	0.18M	2.13M	1.25M	0.64M	1.61M	3.23M	3.63M	1.06M	2.11M	0.12M	0.11M	0.41M	2.39M	1.17M	1.01M	0.01M	0.11M	0.86M	0.01M	0.50M
Other Accumulated Expenses (Quarter)	0.99M	0.62M	0.25M	0.04M	1.43M	2.65M	0.59M	0.52M	0.69M	0.58M	0.51M	0.77M	0.51M	0.46M	0.23M	0.46M	0.12M	0.14M	0.08M	0.22M
Short term Debt (Quarter)	0.41M						1.75M	1.75M						4.93M			0.04M	0.04M	0.04M	0.04M
Current Leases (Quarter)	0.38M	0.41M	0.43M	0.15M	0.39M	0.00M	0.29M	0.17M	0.17M	1.15M	2.22M	2.87M	4.27M	0.20M	0.21M	0.21M	0.22M	0.21M	0.21M	0.16M
Current Taxes (Quarter)								0.01M	0.01M	0.00M	0.00M	0.01M	0.01M	0.02M	0.00M	0.01M	0.01M	0.02M	0.00M	0.00M
Current Deferred Revenue (Quarter)										0.35M	0.19M	0.19M	0.19M			5.33M
Total Current Liabilities (Quarter)	7.68M	4.56M	3.68M	3.68M	7.12M	7.47M	7.65M	5.41M	7.17M	9.63M	6.57M	7.77M	9.60M	9.95M	2.94M	10.44M	2.65M	2.14M	3.11M	3.46M
Non-Current Liabilities
Capital Leases (Quarter)						0.01M
Non-Current Debt (Quarter)							1.21M	0.77M
Convertible Debt (Quarter)										3.45M	6.77M	8.01M	8.89M	32.04M
Non-Current Deffered Revenue (Quarter)								0.25M	0.25M	0.25M	0.39M	0.34M	0.30M
Operating Leases (Quarter)	2.53M	2.41M	2.30M	1.02M	2.43M	2.32M	0.89M	0.84M	34.96M	35.00M	35.07M	36.56M	40.31M	0.53M	0.68M	0.63M	0.38M	0.35M	0.49M	0.23M
Non-Current Deferred Tax Liability (Quarter)
Other Non-Current Liabilities (Quarter)	19.29M	0.02M		13.31M	2.52M	1.69M	0.33M	0.38M	0.11M	0.17M	0.08M	0.19M	0.04M	0.04M	0.00M	0.11M	0.11M	0.11M	0.04M	0.00M
Total Non-Current Liabilities (Quarter)	10.24M	26.33M	6.02M	4.75M	9.60M	10.42M	9.84M	7.35M	42.98M	48.52M	46.81M	52.88M	54.97M	53.07M	3.57M	10.90M	3.03M	2.49M	3.39M	3.68M
Total Liabilities (Quarter)	29.53M	26.35M	6.02M	18.07M	12.12M	12.11M	10.17M	7.73M	43.09M	48.69M	46.90M	53.07M	55.01M	53.11M	3.57M	11.01M	3.14M	2.60M	3.43M	3.68M
Shareholder's Equity
Total Debt (Quarter)	0.41M						2.96M	2.52M						4.93M			0.04M	0.04M	0.04M	0.04M
Common Equity (Quarter)	53.60M	31.53M	25.50M	17.31M	14.78M	8.81M	12.11M	7.38M	3.87M	3.56M	2.23M	-3.41M	-8.53M	-45.39M	1.70M	-5.95M	4.44M	3.57M	2.40M	6.86M
Shareholder's Equity (Quarter)	53.60M	31.53M	25.50M	17.31M	14.78M	8.81M	12.11M	7.38M	3.87M	3.56M	2.23M	-3.41M	-8.53M	-45.39M	1.70M	-5.95M	4.44M	3.57M	2.40M	6.86M
Liabilities and Shareholders Equity (Quarter)	64.71M	39.39M	31.52M	35.38M	26.90M	20.93M	22.28M	15.11M	46.95M	52.25M	49.13M	49.66M	46.49M	7.72M	5.27M	5.06M	7.58M	6.17M	5.83M	10.54M
Treasury Shares (Quarter)			0.01M		0.59M	0.01M	0.00M	0.00M	0.00M	0.00M	0.06M		0.00M	0.00M	0.03M	500.00
Retained Earnings (Quarter)	-46.76M	-132.74M	-140.70M	-150.08M	-153.48M	-160.80M	-165.30M	-170.70M	-175.20M	-180.80M	-186.98M	-193.63M	-199.20M	-225.77M	-231.54M	-239.74M	-242.88M	-244.13M	-245.64M	-251.14M
Preferred Shares (Quarter)	781.00	781.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Shares Outstanding (Quarter)	2.23M	2.60M	2.60M	2.87M	2.87M	2.94M	0.16M	5.13M	5.41M	5.41M	0.36M	0.16M	0.36M	0.16M	0.16M	0.14M	0.16M	7.85M	0.31M	1.17M

Research Tools

Developers

Ernexa Therapeutics Balance Sheet (2010-2026) | ERNAW

Research Tools

Developers

Ernexa Therapeutics Balance Sheet (2010-2026) | ERNAW

Create an account

Sign In

Reset Password